Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
The RESILIENCE project was featured at the Annual Congress of the European Hematology Association (EHA), held in Milan from June 12 to 15th. The session focused on quality of life in oncology patients, with special attention to individuals living with hematological malignancies such as lymphomas and leukemias. Two researchers from the RESILIENCE consortium participated as […]
